Table 1 Baseline characteristics

Age

72.09 (71.68)

54.88–85.24 (7.03)

Total volume (mL)

16.41 (3.16)

0.22–207.70 (34.72)

Gleason score

7.37 (7.0)

5.0–9.0 (1.027)

PSA

18.16 (2.66)

0.09–591.0 (70.96)

Number of metastases

 Oligometastatic (< 3)

38 (41.30)

 Plurimetastatic (≥ 3)

54 (58.70)

 Oligometastatic (< 5)

60 (65.22)

 Plurimetastatic (≥ 5)

32 (34.78)

 Oligometastatic (3 ≤ n < 5)

22 (23.92)

Gleason category

 Gleason (≤ 7)

53 (63.10)

 Gleason (> 7)

31 (36.90)

Ongoing therapy

 YES

33 (35.87)

 NO

59 (64.13)

Initial therapy

 RP

23 (25.0)

 RP + RT

52 (56.52)

 RT

9 (9.78)